Bayer AG
EU lobbying footprint — who they meet, and on what. Built only from official disclosures, every meeting cited.
Bayer AG has 148 disclosed EU lobbying meetings from 2024-07-22 to 2026-06-17: 49 with the European Commission and 99 with Members of the European Parliament. Source: EU Transparency Register no. 3523776801-85, Commission disclosures and MEP declarations.
Lobbying profile
as declared 2026-02-05- Category
- Companies & groups
- Legal status
- Company / Aktiengesellschaft
- Declared lobbying cost
- €6,000,000
- Lobbying FTEs
- 20
- Members
- 10
Files it’s lobbying on
The org's disclosed policy areas, ranked by number of meetings.
Declared fields of interest
Agriculture and rural development · Banking and financial services · Business and industry · Climate action · Competition · Consumers · Customs · Digital economy and society · Economy, finance and the euro · Energy · Environment · Food safety
At a glance
The officials and MEPs most often met, by disclosed-meeting count.
- Olivér Várhelyi3
- Antonella Rossetti3
- Flavio Facioni3
- Wopke Hoekstra2
- Jana Dabbelt2
Disclosed meetings
Newest first, showing the most recent 60 of 148. EC = European Commission, EP = Member of the European Parliament.
- Novel foodsource ↗
- Plant Healthsource ↗
- Women's healthsource ↗
- 2026-05-28ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiChallenges and priorities for health and life sciencessource ↗
- Biotech Actsource ↗
- Austauschsource ↗
- NGTssource ↗
- NGTsource ↗
- NGTssource ↗
- NGT policysource ↗
- Chemical Omnibussource ↗
- New Genomic Techniquessource ↗
- 2026-05-05ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiBiotech Actsource ↗
- Competitive Europe Salon Dinnersource ↗
- EU Biotech Act Isource ↗
- NGTssource ↗
- Environmental Omnibussource ↗
- 2026-04-19ECValdis Dombrovskis · Cabinet of Commissioner Valdis DombrovskisSimplification and competitivenesssource ↗
- 2026-04-16ECAdam Romanowski · Cabinet of Commissioner Maroš ŠefčovičEU-Chinese relations; Food & Feed Safety Omnibussource ↗
- GMMsource ↗
- Food and feed safety onlinesource ↗
- Omnibus Food and Feedsource ↗
- Biotech actsource ↗
- Challenges and Policy Goals in Health Caresource ↗
- 2026-03-04ECAntonella Rossetti · Cabinet of Commissioner Christophe HansenFood and Feed Omnibus – implications for the seed sectorsource ↗
- 2026-03-04ECPatricia Reilly · Cabinet of President Ursula von der LeyenExchange on strategic initiatives shaping innovation and competitiveness in the life sciencessource ↗
- Health Policysource ↗
- Current Topics related to Plant Protection (PFAS, biofuels)source ↗
- Life science industry's connection to competitiveness and growthsource ↗
- Pharmaceutical industrysource ↗
- Health Policysource ↗
- 2026-03-03ECAntti Timonen · Cabinet of Executive Vice-President Henna VirkkunenDiscussion on the outlook of the competitiveness of the life sciences sectorsource ↗
- Food n Feed Safetysource ↗
- Food and Feed Omnibussource ↗
- Chemicals and environmentsource ↗
- Geopolitical Situation in Europe and Defensesource ↗
- 2026-02-13ECWopke Hoekstra · Cabinet of Commissioner Wopke HoekstraRelation EU-US Economic status EU and Germanysource ↗
- 2026-02-13ECJessika Roswall · Cabinet of Commissioner Jessika RoswallPresentation of Bayersource ↗
- Politischer Austauschsource ↗
- Critical Raw Materialssource ↗
- 2026-02-03ECCarmen Laplaza Santos · Head of UnitExchange of views on the competitiveness of the European pharmaceutical sector.source ↗
- 2026-01-13ECTaru Haapaniemi · Cabinet of Commissioner Christophe HansenBiofuels: annex IX RED/intermediate-cover cropssource ↗
- 2026-01-07ECFlavio Facioni · Cabinet of Commissioner Olivér VárhelyiPFAS / TFA yielding pesticidessource ↗
- Triolog NGTssource ↗
- 2025-12-01ECJana Dabbelt · Cabinet of Commissioner Olivér VárhelyiDigital and AI as an enabler in healthcaresource ↗
- 2025-11-04ECEstelle Goeger · Cabinet of Executive Vice-President Stéphane SéjournéOverview of the Commission's Single Market Strategy.source ↗
- Bayer's activities in the iberian peninsula and europesource ↗
- 2025-10-28ECDorota Denning · Cabinet of Commissioner Valdis DombrovskisRoundtable on Simplification for Agricultural Innovationsource ↗
- 2025-10-28ECDorota Denning · Cabinet of Commissioner Valdis DombrovskisRoundtable on Simplification for Pharmaceutical Innovationsource ↗
- Biotech Actsource ↗
- 2025-10-15ECJan Hendrik Dopheide · Cabinet of Commissioner Maroš ŠefčovičEU-UK relationssource ↗
- 2025-10-09ECAndreas Schwarz · Cabinet of Commissioner Ekaterina ZaharievaStartup and Scaleup Strategy; Scaleup Europe Fundsource ↗
- 2025-10-09ECRainer Becker · DirectorBilateral meeting in the margins of the Copenhagen Life Science Summitsource ↗
- 2025-10-09ECIrene Sacristan Sanchez · Head of UnitExchange of views on the state of play of the interinstitutional negotiations on the Commission proposal for a Regulation on plants obtained by certain new genomic techniques (NGT proposal)source ↗
- 2025-10-09ECMartin Seychell · Deputy Director-GeneralBayer strategic approach for the African marketsource ↗
- Medicine marketsource ↗
- NGTssource ↗
- Gene editing and innovation in agriculturesource ↗
- New CAPsource ↗
- NGTssource ↗
Frequently asked
How many EU lobbying meetings has Bayer AG disclosed?
Bayer AG (EU Transparency Register no. 3523776801-85) appears in 148 disclosed meetings with EU officials and MEPs between 2024-07-22 and 2026-06-17: 49 with the European Commission and 99 with Members of the European Parliament.
What does Bayer AG lobby on?
Bayer AG's disclosed EU meetings most often concern Health, Technology, Agriculture, Trade. Every meeting and its topic is listed with its official source on this page.
Who does Bayer AG meet in Brussels?
Across its disclosed meetings, Bayer AG has met Commission officials including Olivér Várhelyi, Antonella Rossetti, Flavio Facioni, and MEPs including LINS Norbert, KULJA András Tivadar, ANDRIUKAITIS Vytenis Povilas. These are counts of officially disclosed meetings, not a measure of influence.
Primary sources
Every meeting above is a public disclosure by the European Commission or a Member of the European Parliament; counts are of disclosed meetings only and are not a measure of influence. Methodology. Data © European Union (Decision 2011/833/EU) & the European Parliament.
Related on the graph
The same footprint, mapped onto the topics and files it touches.
Get the EU lobbying brief
We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.
See your company’s overlap with Bayer AG — and the rest of the corpus.
Enter your company and Lex builds a cited Exposure Map in about 30 seconds. Free, no login.